Abstract

Human ANP32A and ANP32B are essential but redundant host factors for influenza virus genome replication. While most influenza viruses cannot replicate in edited human cells lacking both ANP32A and ANP32B, some strains exhibit limited growth. Here, we experimentally evolve such an influenza A virus in these edited cells and unexpectedly, after 2 passages, we observe robust viral growth. We find two mutations in different subunits of the influenza polymerase that enable the mutant virus to use a novel host factor, ANP32E, an alternative family member, which is unable to support the wild type polymerase. Both mutations reside in the symmetric dimer interface between two polymerase complexes and reduce polymerase dimerization. These mutations have previously been identified as adapting influenza viruses to mice. Indeed, the evolved virus gains the ability to use suboptimal mouse ANP32 proteins and becomes more virulent in mice. We identify further mutations in the symmetric dimer interface which we predict allow influenza to adapt to use suboptimal ANP32 proteins through a similar mechanism. Overall, our results suggest a balance between asymmetric and symmetric dimers of influenza virus polymerase that is influenced by the interaction between polymerase and ANP32 host proteins.

Despite their essentiality, human ANP32A and ANP32B are redundant host factors for influenza virus genome replication. In this work, authors show that an influenza virus grown in cells lacking ANP32A and ANP32B evolved to use ANP32E. They explore the polymerase mutations that enable this, and demonstrate increased virulence in mice.

Details

Title
An Influenza A virus can evolve to use human ANP32E through altering polymerase dimerization
Author
Sheppard, Carol M. 1   VIAFID ORCID Logo  ; Goldhill, Daniel H. 2   VIAFID ORCID Logo  ; Swann, Olivia C. 1 ; Staller, Ecco 3 ; Penn, Rebecca 1 ; Platt, Olivia K. 1   VIAFID ORCID Logo  ; Sukhova, Ksenia 1   VIAFID ORCID Logo  ; Baillon, Laury 1 ; Frise, Rebecca 1 ; Peacock, Thomas P. 1   VIAFID ORCID Logo  ; Fodor, Ervin 3   VIAFID ORCID Logo  ; Barclay, Wendy S. 1   VIAFID ORCID Logo 

 Imperial College London, Department of Infectious Disease, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
 Imperial College London, Department of Infectious Disease, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); Royal Veterinary College, Department of Pathobiology and Population Sciences, London, UK (GRID:grid.20931.39) (ISNI:0000 0004 0425 573X) 
 University of Oxford, Sir William Dunn School of Pathology, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
Pages
6135
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2875213591
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.